MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
17 M |
Marktkapitalisierung |
$ 7.29 M |
EBITDA (LTM) |
$ -21.8 M |
P/E (LTM) |
- |
P/S (LTM) |
0.58 |
EPS (LTM) |
-22.06 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
$ 15.85 | -2.49 % | $ 171 M | Nasdaq Global Market |  China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 115.06 | -0.29 % | $ 35 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.13 | -2.59 % | $ 6.15 M | Nasdaq Capital Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 16.05 | -3.83 % | $ 855 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Interpace Biosciences
IDXG
|
$ 2.3 | - | $ 10.2 M | Nasdaq Global Select Market | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 5.85 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Castle Biosciences
CSTL
|
$ 23.13 | -1.28 % | $ 642 M | Nasdaq Global Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 175.65 | 0.06 % | $ 8.71 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 493.53 | -1.59 % | $ 14.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 189.61 | -1.7 % | $ 135 B | NYSE,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 120.93 | -2.22 % | $ 19.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.35 | -2.03 % | $ 403 M | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 14.43 | -3.93 % | $ 436 M | Nasdaq Global Market | USA |
 |
NeoGenomics
NEO
|
$ 7.69 | -3.17 % | $ 985 M | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 78.6 | -9.83 % | $ 9.85 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Anixa Biosciences
ANIX
|
$ 2.69 | -1.82 % | $ 87.3 K | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.13 | -0.9 % | $ 4.89 M | Nasdaq Capital Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 28.31 | 0.62 % | $ 20 B | NYSE | Niderland |
 |
ICON Public Limited Company
ICLR
|
$ 106.81 | 0.1 % | $ 8.81 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 260.93 | -4.51 % | $ 21.7 B | NYSE,SPB | USA |
 |
Natera
NTRA
|
$ 193.03 | -4.91 % | $ 19 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 117.14 | -6.02 % | $ 5.48 B | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 80.59 | -1.03 % | $ 5.44 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 6.68 | 0.15 % | $ 279 M | NYSE American | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Soleno Therapeutics
SLNO
|
$ 52.63 | 0.23 % | $ 2.67 B | Nasdaq Capital Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 191.51 | -3.19 % | $ 21.3 B | NYSE,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.42 | -6.13 % | $ 2.04 B | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.94 | -6.97 % | $ 3.89 M | Nasdaq Global Select Market | USA |
 |
Neuronetics
STIM
|
$ 1.35 | -2.17 % | $ 89 M | Nasdaq Global Select Market | USA |
 |
National Research Corporation
NRC
|
$ 16.48 | -3.34 % | $ 369 M | Nasdaq Global Select Market | USA |